ストックスクリーナーアプリを入手
2.43
1.25%
0.03
アフターアワーズ：
2.53
0.10
+4.12%
Heartbeam Inc (BEAT) 最新ニュース
How HeartBeam Inc. Equity Warrant stock reacts to global recession fearsGlobal Trade Effects & Small Budget Trading Ideas - bollywoodhelpline.com
Pharma News: What sentiment indicators say about HeartBeam Inc stockRisk Management & High Conviction Investment Ideas - moha.gov.vn
HeartBeam seeks FDA nod for ECG synthesis software - MSN
HeartBeam Stock Slumps After FDA Refuses Clearance For ECG Software - MSN
HeartBeam shares skyrocket after FDA signs off on 12-lead ECG synthesis software - MSN
Major HeartBeam Investor Makes Bold Move With Eye-Catching Stock Sale - TipRanks
Heartbeam Insider Sold Shares Worth $895,000, According to a Recent SEC Filing - marketscreener.com
Earnings Beat: How institutional buying supports Alector Inc stock2025 Market WrapUp & Weekly Breakout Opportunity Watchlist - moha.gov.vn
Will HeartBeam Inc. stock deliver shareholder value2025 Macro Impact & Free Real-Time Market Sentiment Alerts - ulpravda.ru
What Wall Street predicts for HeartBeam Inc. Equity Warrant stock price2025 Buyback Activity & Free Reliable Trade Execution Plans - Улправда
Is HeartBeam Inc. Equity Warrant stock safe for conservative investors2025 Bull vs Bear & AI Forecast for Swing Trade Picks - Улправда
How HeartBeam Inc. stock performs in stagflation2025 Volatility Report & Low Risk Investment Opportunities - Улправда
Trend Report: Will HeartBeam Inc. stock deliver shareholder valueMarket Activity Summary & Free High Accuracy Swing Entry Alerts - Улправда
Can HeartBeam Inc. stock double in next 5 yearsWeekly Profit Recap & Step-by-Step Trade Execution Guides - Улправда
Will HeartBeam Inc. Equity Warrant stock benefit from upcoming earnings reports2025 Bull vs Bear & Free Community Consensus Stock Picks - Улправда
Patterns Watch: Can HeartBeam Inc. stock hit analyst price targetsPortfolio Update Summary & Weekly Sector Rotation Insights - ulpravda.ru
HeartBeam Director George de Urioste Sells All Common Stock Holdings - TradingView — Track All Markets
How risky is HeartBeam Inc. Equity Warrant stock nowJuly 2025 Decliners & Expert Verified Movement Alerts - Улправда
Is HeartBeam Inc. Equity Warrant stock a bargain at current levels2025 Market WrapUp & Free Expert Verified Stock Movement Alerts - Улправда
How institutional buying supports HeartBeam Inc. Equity Warrant stockPrice Action & High Accuracy Investment Signals - Улправда
Why HeartBeam Inc. Equity Warrant stock is a must watch in 2025Gap Up & Daily Entry Point Trade Alerts - DonanımHaber
Is HeartBeam Inc. stock dividend yield sustainable2025 Biggest Moves & Long Hold Capital Preservation Tips - Улправда
What sentiment indicators say about HeartBeam Inc. stockJuly 2025 Reactions & Entry Point Confirmation Signals - DonanımHaber
Will HeartBeam Inc. Equity Warrant stock deliver consistent dividendsWeekly Profit Summary & Stepwise Trade Signal Guides - DonanımHaber
How HeartBeam Inc. stock performs in interest rate cyclesTrade Exit Summary & Smart Money Movement Tracker - DonanımHaber
HeartBeam (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation - The Globe and Mail
HeartBeam (BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation - NewMediaWire
HeartBeam (NASDAQ: BEAT) ranks second worldwide in 12-lead ECG innovation - MSN
Will HeartBeam Inc. Equity Warrant stock outperform tech sector in 2025Market Trend Summary & Precise Trade Entry Recommendations - Улправда
Rate Cut: How HeartBeam Inc. Equity Warrant stock reacts to global recession fearsMarket Volume Report & Capital Protection Trade Alerts - Улправда
Analyst Downgrade: How institutional buying supports HeartBeam Inc. Equity Warrant stock2025 Valuation Update & Detailed Earnings Play Alerts - Улправда
ETFs Investing in Heartbeam, Inc. Stocks - TradingView — Track All Markets
HeartBeam Shares Tumble: Road to Recovery? - StocksToTrade
AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation - FinancialContent
HeartBeam (BEAT) Stock News Today: FDA Clearance Ignites Rally, Analysts Lift Targets, and What Investors Are Watching Next (Dec. 17, 2025) - ts2.tech
HeartBeam Earns FDA Clearance for 12-Lead Synthesis Software - Diagnostic and Interventional Cardiology
HeartBeam Stock Surges 388%, With A 9-Day Winning Spree - Trefis
HeartBeam’s Stock Soars After FDA Clearance for Innovative ECG Technology - StocksToTrade
HeartBeam Stock Surges 273%, With A 8-Day Winning Spree - Trefis
HeartBeam Stock 7-Day Winning Spree: Stock Climbs 227% - Trefis
Heartbeam Inc. (BEAT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
HeartBeam Shares Skyrocket: FDA Boost - timothysykes.com
HeartBeam Soars with FDA Approval for Breakthrough ECG Technology - timothysykes.com
HeartBeam Stock Soars: Should You Buy? - timothysykes.com
symbol__ Stock Quote Price and Forecast - CNN
Heartbeam stock is a buy, this analyst says - Cantech Letter
HeartBeam Stock Surges 201%, With A 6-Day Winning Spree - Trefis
Benchmark Upgrades HeartBeam (BEAT) - Nasdaq
1.90%
0.62%
大文字化:
|
ボリューム (24 時間):